Glycophos

Glycophos is a prescription intravenous solution containing the active ingredient sodium glycerophosphate pentahydrate. The product’s strength is not specified in the available data, and it is marketed within the European Union. As a phosphate supplement, Glycophos is administered by healthcare professionals to address conditions associated with low serum phosphate levels.

Glycophos is indicated for the treatment of phosphate depletion and related metabolic disturbances. It is used in clinical settings where rapid restoration of serum phosphate is required.

- Management of hypophosphatemia in hospitalized patients - Support during prolonged parenteral nutrition - Correction of phosphate loss after major surgery or trauma - Adjunct therapy in patients receiving continuous renal replacement therapy - Treatment of phosphate deficiency associated with refeeding syndrome

Side effects of Glycophos may vary in frequency and severity. Patients should be monitored for any adverse reactions during and after infusion.

Common: - Mild local irritation at the infusion site - Transient hyperphosphatemia - Nausea or vomiting - Headache - Flushing or warmth sensation

Serious: - Severe hyperphosphatemia leading to calcium-phosphate precipitation - Allergic reactions such as rash, itching, or anaphylaxis - Hypotension due to rapid infusion - Metabolic acidosis in susceptible individuals

When using Glycophos, clinicians should consider several safety factors to minimize risks.

- Assess baseline serum phosphate, calcium, and renal function before administration - Adjust dose in patients with renal impairment or severe hyperphosphatemia - Infuse at the recommended rate to avoid rapid shifts in phosphate levels - Monitor electrolytes and acid‑base status during therapy - Use caution in patients with a history of hypersensitivity to phosphate preparations - Discontinue if signs of severe hyperphosphatemia or allergic reaction develop

Glycophos may interact with other medications or clinical conditions. Awareness of these interactions helps guide safe use.

Avoid: - Concurrent administration of calcium-containing solutions that may precipitate with phosphate - High-dose vitamin D analogues that increase calcium absorption, raising risk of calcium‑phosphate precipitation

Use with caution: - Loop diuretics, which can affect electrolyte balance - Antacids containing aluminum or magnesium, which may alter phosphate absorption - Blood transfusions, as citrate may bind calcium and affect phosphate dynamics - Medications that affect renal function, such as aminoglycosides or NSAIDs